Manila Integrated Environment Corp. (MIEC), a company majority owned by Phil. Ecology Systems Corp. (PHILECO), proposed to ...

Researchers at the Beijing Institute of Technology have unveiled an innovative electrothermal microgripper that promises to ...

Nearly 90% of van fleets are choosing operating lease as their preferred funding method, FN50 research has found.

Despite research showing the benefits of circulating tumor DNA as an indicator of disease remission in B-cell lymphoma, ...

Myriad continues to develop its Precise MRD assay to meet the needs of patients with cancer, academic partners, and biopharma ...

Inflation ran hotter than forecasters expected in January, but a quirk of the data involving seasonal adjustment means many economists have stopped short of declaring inflation has reignited.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and tumor genomic testing and precision medicine, announced that the United States Patent and ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

molecular residual disease assay to market. U.S. patent No. 12,215,391 relates to Myriad’s proprietary automated methods of MRD analysis. Specifically, the claims are relevant to certain MRD methods ...

To answer these questions, we need to know how exactly bending speed affects the forming of various metal types and provide ...

“Yes, sometimes we can see things visually by looking at a part,” said Connor Callais, product manager at Hubbard-Hall.